ARID4B and intrahepatic cholangiocarcinoma: Previous reports have highlighted increased BCAA levels in the plasma/sera and tissue samples of patients with breast cancer 47, and pancreatic cancer 48, whereas, downregulated protein expressions in BCAA pathway in intrahepatic cholangiocarcinoma 49.